The safety and tolerability of sumpatriptan: An overview

European Neurology

Volumn 31, Issue 5, 1991, Pages 339-344

  Brown, E G ^a   Endersby, C A ^a   Smith, R N ^a   Talbot, J C C ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

adverse events; oral administration; precautions in use; subcutaneous injection; sumatriptan

Indexed keywords

SUMATRIPTAN; INDOLE DERIVATIVE; SULFONAMIDE; VASOCONSTRICTOR AGENT;

ADVERSE DRUG REACTION; CONFERENCE PAPER; DRUG TOXICITY; HUMAN; MIGRAINE; PRIORITY JOURNAL; SAFETY; SUBCUTANEOUS DRUG ADMINISTRATION; ADULT; AGED; ARTICLE; CLINICAL TRIAL; ELECTROCARDIOGRAPHY; FEMALE; MALE; MONITORING; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ELECTROCARDIOGRAPHY; FEMALE; HUMAN; INDOLES; MALE; MIDDLE AGE; MIGRAINE; MONITORING, PHYSIOLOGIC; SULFONAMIDES; SUMATRIPTAN; VASOCONSTRICTOR AGENTS;

EID: 0025923321     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000116762     Document Type: Conference Paper

References (0)